Posters - NCDEU: An Annual Meeting Sponsored by ASCP

Posters
23. Relapse Rates in Psychotic Depression are Lower than in
Non-psychotic Depression after a Successful Course of
Electroconvulsive Therapy (ECT)
Georgios Petrides, The Zucker Hillside Hospital, Northshore-LIJ Health
System
Rebecca Knapp, Mustafa Husain, Teresa Rummans, Max Fink,
Martina Mueller, Samuel Bailine, Charles Kellner
24. Surveillance Strategies to Improve Study Outcomes in a
Depression Study
Manny Asgharnejad, CeNeRx
Steven Targum, Daniel Burch, Michael Gibertini, Maurizio Fava
25. Levomilnacipran in the Treatment of Major Depressive Disorder:
Functional Health and Well-being Efficacy Results From a Phase
III Clinical Trial
Steven Blum, Forest Research Institute
Stavros Tourkodimitris, Adam Ruth
26. Levomilnacipran in the Treatment of Major Depressive Disorder:
An Analysis of Efficacy Data From 2 Phase III Studies
Anjana Bose, Forest Research Institute
Carl Gommoll, Hua Li, Adam Ruth, Tobie Escher
27. Early and Sustained Response Achieved Across Multiple
Measures with Adjunctive Aripiprazole in MDD Patients with an
Inadequate Response to Antidepressant Monotherapy
Daniel Casey, Oregon Health and Science University
Kimberly Laubmeier, James Eudicone, Ronald Marcus, Robert
Berman, Ross Baker, Jack Sheehan
28. Selegiline Transdermal System (STS) for Major Depressive
Disorder (MDD): Use Pattern, Adherence, and Effect on Health
Service Expenditures
Lawrence Cohen, Washington State University
David Sclar, Kimberly Portland
29. The Efficacy of Levomilnacipran in the Treatment of Major
Depressive Disorder: Results from a Phase III Clinical Trial
Tobie Escher, Forest Research Institute
Carl Gommoll, Anjana Bose, Changzheng Chen, Adam Ruth
= New Investigator Awardee
85